Biomedical and Entrepreneurship Training for Aging (BETA)

预计到2050年，美国65岁的≥人口比例将达到22%.医疗创新在改善老年人口的健康和福祉方面发挥了关键作用。然而，学术界和产业界之间仍然存在一个重大鸿沟，必须弥合这一鸿沟，以推动新药、设备和技术的创新和商业化，以对抗与年龄相关的疾病，包括阿尔茨海默病(AD)和阿尔茨海默病相关痴呆(ADRD)。在年龄相关疾病方面接受高级培训的研究生和博士后实习生构成了一支有能力填补这一空白的重要劳动力；然而，目前的培训方案没有提供必要的商业和沟通技能，使这些实习生能够填补这一空白。该应用程序的总体目标是通过创建生物医学创业老年培训(BETA)计划来发展促进健康老龄化的科学工作队伍。墨尔本大学非常适合作为教育项目的中心，专注于研究生和博士后在老龄相关学科的职业生涯，因为它将医学院、工程学院、卫生专业学院、护理学院、新闻学院和全面的密歇根大学卫生系统合并在一个校园内。墨尔本大学拥有支持创业教育的杰出项目，包括生命科学创新与创业研究生计划、中西部生物医学加速器联盟、美国国立卫生研究院资助的研究评估和商业化中心(REACH)、库尔特生物医学加速器和密歇根大学生命科学企业孵化器。密苏里大学系统拥有70,000名学生和数百个研究生课程，提供了强大的Beta学员来源，包括密苏里大学堪萨斯城分校(UMKC)应用认知和脑科学博士课程密苏里大学圣彼得堡分校的密歇根大学跨学科神经科学研究生培训计划。路易斯大学行为神经科学博士项目和密苏里州S生物科学研究生项目。墨尔本大学还与哈佛大学林肯大学建立了长期的合作伙伴关系，该大学将为学生提供资源，以实现多样性和包容性。Beta利用全州范围内的UM系统的商业化和教育专业知识来创建一个网络，招募和指导一系列不同的受训人员，并为他们提供所需的生物医学创新和沟通技能，使他们成为致力于改善老龄化人口健康和福祉的科学工作队伍中高生产率的成员。

The proportion of the US population of ≥65 years of age is expected to reach 22% by 2050. Healthcare innovations have played a crucial role in improving the health and well-being of the elderly population. Nevertheless, a major gap persists between academia and industry that must be bridged to drive innovation and commercialization of new drugs, devices, and technologies to combat age-related disorders, including Alzheimer’s disease (AD) and Alzheimer’s Disease related dementia (ADRD). Graduate students and post-doctoral trainees pursuing advanced training in age-related diseases constitute a vital work force capable of filling this gap; however, current training programs do not provide the business and communication skills needed to empower these trainees to fill this void. The overarching objective of the application is to grow the scientific work force promoting healthy aging through the creation of the Biomedical Entrepreneurship Training for Aging (BETA) program. MU is ideally suited to serve as the hub of an educational program focusing on graduate students and postdoctoral fellows pursuing careers in aging-related disciplines, as it co-localizes on one campus a school of medicine, college of engineering, school of health professions, college of nursing, school of journalism, and the comprehensive UM Health System. MU has outstanding programs that support entrepreneurial education, including the Life Science Innovation & Entrepreneurship Graduate Program, the Midwest Biomedical Accelerator Consortium, an NIH-funded Research Evaluation and Commercialization Hub (REACH), a Coulter Biomedical Accelerator, and the MU Life Science Business Incubator. The UM System, with >70,000 students and hundreds of graduate programs, provides a robust source of BETA trainees, including the MU Interdisciplinary Neuroscience Graduate Training Program, University of Missouri-Kansas City (UMKC) Doctoral Program in Applied Cognitive &Brain Sciences, University of Missouri-St. Louis (UMSL) Behavioral Neuroscience PhD program, and the Missouri S&T (MS&T) Graduate Program in Biological Sciences. MU also has a long-standing partnership with Lincoln University, an HBU that will source students to enable diversity and inclusion. BETA leverages the commercialization and educational expertise of the statewide UM System to create a network that recruits and mentors a diverse array of trainees and provides them with the biomedical innovation and communication skills needed to become highly productive members of the scientific work force devoted to improving the health and wellbeing of the aging population.